FDA NDC Directory · JSON-LD · Markdown

NOVOLOG

NDC 0169-6338 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin aspart
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA020986
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsINSULIN ASPART (100 [iU]/mL)
Marketing started20131031
Package count0

External sources

Source: openFDA. Public-domain (CC0).